A randomized clinical trial for a self-guided sleep intervention following moderate-severe traumatic brain injury: Study protocol

Molly J. Sullan,Adam R. Kinney,Kelly A. Stearns-Yoder,Daniel J. Reis,Emerald G. Saldyt,Jeri E. Forster,Chelsea M. Cogan,Nazanin H. Bahraini,Lisa A. Brenner
DOI: https://doi.org/10.1016/j.cct.2024.107525
IF: 2.261
2024-04-11
Contemporary Clinical Trials
Abstract:Background Individuals with a history of moderate-severe traumatic brain injury (TBI) experience a significantly higher prevalence of insomnia compared to the general population. While individuals living with TBI have been shown to benefit from traditional insomnia interventions (e.g., face-to-face [F2F]), such as Cognitive Behavioral Therapy for Insomnia (CBTI), many barriers exist that limit access to F2F evidence-based treatments. Although computerized CBT-I (CCBT-I) is efficacious in terms of reducing insomnia symptoms, individuals with moderate-severe TBI may require support to engage in such treatment. Here we describe the rationale, design, and methods of a randomized controlled trial (RCT) assessing the efficacy of a guided CCBT-I program for reducing insomnia symptoms for participants with a history of moderate-severe TBI. Methods This is an RCT of a guided CCBT-I intervention for individuals with a history of moderate-severe TBI and insomnia. The primary outcome is self-reported insomnia severity, pre- to post-intervention. Exploratory outcomes include changes in sleep misperception following CCBT-I and describing the nature of guidance needed by the Study Clinician during the intervention. Conclusion This study represents an innovative approach to facilitating broader engagement with an evidence-based online treatment for insomnia among those with a history of moderate-severe TBI. Findings will provide evidence for the level and nature of support needed to implement guided CCBT-I. Should findings be positive, this study would provide support for a strategy by which to deliver guided CCBT-I to individuals with a history of moderate-severe TBI.
pharmacology & pharmacy,medicine, research & experimental
What problem does this paper attempt to address?